Miller Steve (CIK 1402535) reported 7 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-17). Recent activity: Sell CPRX (1.1M shares), Buy CPRX (14,000 shares), Buy CPRX (11,873 shares), Buy CPRX (8,267 shares), Buy CPRX (115,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-17 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Chief Op. & Scientific Officer | Sell | 1.1M | $34.5M |
| 2025-12-30 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Chief Op. & Scientific Officer | Buy | 14,000 | $0 |
| 2025-12-10 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Chief Op. & Scientific Officer | Buy | 11,873 | $0 |
| 2025-11-24 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Chief Op. & Scientific Officer | Buy | 8,267 | $0 |
| 2025-08-28 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Chief Op. & Scientific Officer | Buy | 115,000 | $257,600 |
| 2025-08-28 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Chief Op. & Scientific Officer | Sell | 115,000 | $2.3M |
| 2025-08-28 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Chief Op. & Scientific Officer | Buy | 110,000 | $246,400 |
Source: SEC Form 4 filings · as of 2026-07-17